Tags

Type your tag names separated by a space and hit enter

INTRAVITREAL TRIAMCINOLONE IN SUSAC SYNDROME.
Retin Cases Brief Rep 2017 Summer; 11(3):236-239RC

Abstract

PURPOSE

To report the use of intravitreal triamcinolone for Susac Syndrome in one patient.

METHODS

Case report.

RESULTS

A 23-year-old woman presented with presented with sudden visual loss in the left eye with associated neurologic symptoms. Ophthalmic examination and fluorescein angiography showed multiple areas of branch retinal artery occlusion, bilaterally. Magnetic resonance imaging showed dot-like, diffusion-restricted lesions in the corpus callosum, and audiometry showed low-frequency sensory hearing loss, compatible with Susac Syndrome. The patient received a single intravitreal injection of triamcinolone (4 mg) in the left eye. One week later, before beginning systemic corticosteroids, all signs and symptoms resolved in the left eye only.

CONCLUSION

In cases of delayed systemic corticosteroid therapy, intravitreal triamcinolone resolves the ocular manifestations of Susac Syndrome.

Authors+Show Affiliations

*Vitreoretinal Surgery Department, Clinica de Ojos, Maracaibo, Venezuela; and †Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

27276498

Citation

Yepez, Juan B., et al. "INTRAVITREAL TRIAMCINOLONE in SUSAC SYNDROME." Retinal Cases & Brief Reports, vol. 11, no. 3, 2017, pp. 236-239.
Yepez JB, Murati FA, Pettito M, et al. INTRAVITREAL TRIAMCINOLONE IN SUSAC SYNDROME. Retin Cases Brief Rep. 2017;11(3):236-239.
Yepez, J. B., Murati, F. A., Pettito, M., & Arevalo, J. F. (2017). INTRAVITREAL TRIAMCINOLONE IN SUSAC SYNDROME. Retinal Cases & Brief Reports, 11(3), pp. 236-239. doi:10.1097/ICB.0000000000000344.
Yepez JB, et al. INTRAVITREAL TRIAMCINOLONE in SUSAC SYNDROME. Retin Cases Brief Rep. 2017;11(3):236-239. PubMed PMID: 27276498.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - INTRAVITREAL TRIAMCINOLONE IN SUSAC SYNDROME. AU - Yepez,Juan B, AU - Murati,Felipe A, AU - Pettito,Michele, AU - Arevalo,J Fernando, PY - 2016/6/9/pubmed PY - 2018/1/9/medline PY - 2016/6/9/entrez SP - 236 EP - 239 JF - Retinal cases & brief reports JO - Retin Cases Brief Rep VL - 11 IS - 3 N2 - PURPOSE: To report the use of intravitreal triamcinolone for Susac Syndrome in one patient. METHODS: Case report. RESULTS: A 23-year-old woman presented with presented with sudden visual loss in the left eye with associated neurologic symptoms. Ophthalmic examination and fluorescein angiography showed multiple areas of branch retinal artery occlusion, bilaterally. Magnetic resonance imaging showed dot-like, diffusion-restricted lesions in the corpus callosum, and audiometry showed low-frequency sensory hearing loss, compatible with Susac Syndrome. The patient received a single intravitreal injection of triamcinolone (4 mg) in the left eye. One week later, before beginning systemic corticosteroids, all signs and symptoms resolved in the left eye only. CONCLUSION: In cases of delayed systemic corticosteroid therapy, intravitreal triamcinolone resolves the ocular manifestations of Susac Syndrome. SN - 1937-1578 UR - https://www.unboundmedicine.com/medline/citation/27276498/INTRAVITREAL_TRIAMCINOLONE_IN_SUSAC_SYNDROME_ L2 - http://Insights.ovid.com/pubmed?pmid=27276498 DB - PRIME DP - Unbound Medicine ER -